pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents.

To investigate the delivery of hydrophobic therapeutic agents, a new class of polymer carriers was synthesized. These carriers are composed of two components: (i) a pH-responsive hydrogel composed of methacrylic acid grafted with poly(ethylene glycol) tethers, P(MAA-g-EG), and (ii) hydrophobic poly(methyl methacrylate) (PMMA) nanoparticles. Before the P(MAA-g-EG) hydrogel was crosslinked, PMMA nanoparticles were added to the solution and upon exposure to UV light they were photoencapsulated throughout the P(MAA-g-EG) hydrogel structure. The pH-responsive behavior of P(MAA-g-EG) is capable of triggered release of a loaded therapeutic agent, such as a low molecular weight drug or protein, when it passes from the stomach (low pH) to upper small intestine (neutral pH). The introduction of PMMA nanoparticles into the hydrogel structure affected the swelling behavior, therapeutic agent loading efficiency, and solute release profiles. In equilibrium swelling conditions the swelling ratio of nanoparticle-containing hydrogels decreased with increasing nanoparticle content. Loading efficiencies of the model therapeutic agent fluorescein ranged from 38 - 51 % and increased with increasing hydrophobic content. Release studies from neat P(MAA-g-EG) and the ensuing P(MAA-g-EG) hydrogels containing nanoparticles indicated that the transition from low pH (2.0) to neutral pH (7.0) triggered fluorescein release. Maximum fluorescein release depended on the structure and hydrophobicity of the carriers used in these studies.

[1]  Nicholas A Peppas,et al.  Complexation Hydrogels for the Oral Delivery of Growth Hormone and Salmon Calcitonin. , 2010, Industrial & engineering chemistry research.

[2]  N A Peppas,et al.  Water, solute and protein diffusion in physiologically responsive hydrogels of poly (methacrylic acid-g-ethylene glycol). , 1996, Biomaterials.

[3]  Nicholas A Peppas,et al.  Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery. , 2008, Biomacromolecules.

[4]  H. Ishitsuka,et al.  Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. , 1998, European journal of cancer.

[5]  Jing Zhang,et al.  Synthesis and Characterization of pH- and Temperature-Sensitive Poly(methacrylic acid)/Poly(N-isopropylacrylamide) Interpenetrating Polymeric Networks , 2000 .

[6]  A. Balmain,et al.  Genomic approaches to identification of tumour-susceptibility genes using mouse models. , 2003, Current opinion in genetics & development.

[7]  Nicholas A Peppas,et al.  Complexation hydrogels for intestinal delivery of interferon beta and calcitonin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Li Shi,et al.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers , 2010, Expert opinion on drug delivery.

[9]  N. Peppas,et al.  Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates. , 2006, Biomaterials.

[10]  N. Peppas,et al.  Hydrogels in Pharmaceutical Formulations , 1999 .

[11]  Nicholas A Peppas,et al.  Hydrogels for oral delivery of therapeutic proteins , 2004, Expert opinion on biological therapy.

[12]  Microstructured polyacrylamide hydrogels made with hydrophobic nanoparticles. , 2004, Journal of colloid and interface science.

[13]  N. Peppas,et al.  Preparation and Characterization of pH-Responsive Poly(methacrylic acid-g-ethylene glycol) Nanospheres , 2002 .

[14]  N. Peppas,et al.  Oral delivery of insulin using pH-responsive complexation gels. , 1999, Journal of pharmaceutical sciences.

[15]  N. Peppas,et al.  Stimuli-sensitive protein delivery systems , 2006 .

[16]  V. Bondar,et al.  Colloidal stability of modified nanodiamond particles , 2009 .

[17]  Mehrdad Hamidi,et al.  Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.

[18]  R. Misra,et al.  Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. , 2010, Acta biomaterialia.

[19]  M. Torres-Lugo,et al.  Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin , 1999 .

[20]  V. Satyanarayana,et al.  In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  N. Peppas,et al.  Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[22]  J. Blanchette,et al.  Oral Chemotherapeutic Delivery: Design and Cellular Response , 2005, Annals of Biomedical Engineering.

[23]  J. Pomposo,et al.  Metal-Free Polymethyl Methacrylate (PMMA) Nanoparticles by Enamine “Click” Chemistry at Room Temperature , 2011 .

[24]  Oğuz Balci,et al.  Size controlled synthesis of sub-100 nm monodisperse poly(methylmethacrylate) nanoparticles using surfactant-free emulsion polymerization. , 2010, Journal of colloid and interface science.

[25]  Noriho Tanaka,et al.  An assay method for the prediction of tumor promoting potential of chemicals by the use of Bhas 42 cells. , 2004, Mutation research.

[26]  Francis J. Doyle,et al.  Dynamic Behavior of Glucose-Responsive Poly(methacrylic acid-g-ethylene glycol) Hydrogels , 1997 .

[27]  E. Warner,et al.  Patient preferences for oral versus intravenous palliative chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  V. Sinha,et al.  Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs. , 1999, Drugs of today.

[29]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[30]  V. Heinemann,et al.  Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced Pancreatic Cancer , 2008, Oncology.

[31]  D. Wölfle.  Enhancement of carcinogen-induced malignant cell transformation by prostaglandin F2α , 2003 .

[32]  Hua Song,et al.  Sustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix , 2011, Nanoscale research letters.

[33]  J. Blanchette,et al.  Principles of Transmucosal Delivery of Therapeutic Agents , 2004 .

[34]  Ales Prokop,et al.  Kinetic analysis of nanoparticulate polyelectrolyte complex interactions with endothelial cells. , 2007, Biomaterials.

[35]  N. Maisey,et al.  Considerations when choosing oral chemotherapy: identifying and responding to patient need , 2010 .

[36]  B. Sreedhar,et al.  Hydrogel–silver nanoparticle composites: A new generation of antimicrobials† , 2010 .

[37]  Nicholas A Peppas,et al.  Amphiphilic Interpenetrating Networks for the Delivery of Hydrophobic, Low Molecular Weight Therapeutic Agents. , 2011, Industrial & engineering chemistry research.

[38]  D. Schrenk,et al.  Tumor promoters as inhibitors of apoptosis in rat hepatocytes. , 2003, Toxicology letters.

[39]  R. Somer,et al.  Novel approach to Gorlin syndrome: a patient treated with oral capecitabine. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Xianghui Xu,et al.  Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[41]  E. Van Cutsem,et al.  Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Dany J. Munoz-Pinto,et al.  Photo-cross-linked PDMSstar-PEG hydrogels: synthesis, characterization, and potential application for tissue engineering scaffolds. , 2010, Biomacromolecules.

[43]  J. Blanchette,et al.  Cellular evaluation of oral chemotherapy carriers. , 2005, Journal of biomedical materials research. Part A.

[44]  Courtney M. Creecy,et al.  Dynamics of Poly(ethylene glycol)-Tethered, pH Responsive Networks. , 2007, Polymer.

[45]  N. Peppas,et al.  Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. , 2004, Journal of controlled release : official journal of the Controlled Release Society.